← Leaderboards
Ho Lam Tang
Johns Hopkins University
$3,229,453
Attributed
$3,229,453
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $880.2K · FY2017–25$1M$750K$500K$250K$0
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,229,453 · 5
By mechanism
R35$1,477,015 · 1
R21$1,266,438 · 3
K22$486,000 · 1
Top collaborators
No co-investigators on record.
Most similar at Johns Hopkins University
Same institution · by research overlap
- Vincent W. Yang$29,529,911
- Irina Petrache$14,015,590
- Joseph A Califano$16,242,638
- Constance A Griffin$6,423,088
- Gary S Hayward$11,890,978
Others in their field
Other Emerging Leaders on “Apoptotic”
- Avnesh Sinh Thakor · Stanford University$4,321,167
- Bishuang Cai · Icahn School Of Medicine At Mount Sinai$3,775,001
- Tomokazu Souma · Duke University$3,688,219
- Jean Kwun · Duke University$3,442,852
- Russell Dahl · Neurodon Llc$3,365,969
- Ada Weinstock · New York University School Of Medicine$3,255,832
Research focus
ApoptoticCessation Of LifeCellsRecoveryCell DeathCancer TherapyCancer CellRecurrenceApoptosisMorphologyBiosensorCancer Cell LineIn VivoAnimalsPathologicCasp3 GeneCell SurvivalFoundationsMolecularPlayInsightExhibitsDrosophila GenusHomeostasis
Grant awards (12)
Anastasis: A Novel Cell Survival Mechanism$409,375
R35 · FY2025 · GM · contact PI
Detecting Reversal of Apoptosis in Cancer Cells in Mice$191,383
R21 · FY2025 · CA · contact PI
Anastasis: A Novel Cell Survival Mechanism$409,375
R35 · FY2024 · GM · contact PI
Anastasis: A Novel Cell Survival Mechanism$248,890
R35 · FY2024 · GM · contact PI
Detecting Reversal of Apoptosis in Cancer Cells in Mice$221,911
R21 · FY2024 · CA · contact PI
Anastasis: A Novel Cell Survival Mechanism$409,375
R35 · FY2023 · GM · contact PI
Anastasis biosensor for tracking reversal of apoptosis in vivo$204,688
R21 · FY2021 · OD · contact PI
Elucidating connections between anastasis and cancer drug resistance$411,118
R21 · FY2020 · CA · contact PI
Anastasis biosensor for tracking reversal of apoptosis in vivo$237,338
R21 · FY2020 · OD · contact PI
Cell survival by anastasis, a novel therapeutic target in cancer$162,000
K22 · FY2019 · CA · contact PI
Cell survival by anastasis, a novel therapeutic target in cancer$162,000
K22 · FY2018 · CA · contact PI
Cell survival by anastasis, a novel therapeutic target in cancer$162,000
K22 · FY2017 · CA · contact PI